Invesaro

Stocks Comparison

biote vs Cronos: revenue, profit, margins and growth compared

biote brought in $192.2M of revenue in fiscal 2025, Cronos $193.4M in fiscal 2025. Revenue changed by -2.5% at biote and +19.5% at Cronos on the year before, so Cronos grew faster. biote kept 14.1% of its revenue as net profit, Cronos -4.9%. Free cash flow was $30.2M at biote and $149K at Cronos.

Side by side, latest fiscal year

BTMDCRON
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$192.2M$193.4M
Revenue growth-2.5%+19.5%
Net income$27M-$9.4M
Net margin14.1%-4.9%
Free cash flow$30.2M$149K
Free cash flow margin15.7%0.1%
Earnings per share (diluted)$0.74-$0.02
Cash$24.1M$791.8M
Debt$103.1Mn/a
Price to earnings1.6n/a
Market value$43.8M$1.2B
Dividend yieldn/an/a
Rank by revenue in sector#256 of 523 · Health care#254 of 523 · Health care

Over the years

Revenue
BTMD FY2021: $139.4MBTMD FY2022: $165MBTMD FY2023: $185.4MBTMD FY2024: $197.2MBTMD FY2025: $192.2MCRON FY2019: $13.2MCRON FY2019: $25.6MCRON FY2020: $54.4MCRON FY2021: $79.6MCRON FY2022: $109.3MCRON FY2023: $120.3MCRON FY2024: $161.8MCRON FY2025: $193.4MFY19FY20FY21FY22FY23FY24FY25
BTMD $192.2MCRON $193.4M
Net income
BTMD FY2021: $11.1MBTMD FY2022: -$969KBTMD FY2023: $3.3MBTMD FY2024: $3.2MBTMD FY2025: $27MCRON FY2019: -$21.6MCRON FY2019: $1.2BCRON FY2020: -$73.1MCRON FY2021: -$396.1MCRON FY2022: -$168.7MCRON FY2023: -$74MCRON FY2024: $41.1MCRON FY2025: -$9.4MFY19FY20FY21FY22FY23FY24FY25
BTMD $27MCRON -$9.4M
Net margin
BTMD FY2021: 8.0%BTMD FY2022: -0.6%BTMD FY2023: 1.8%BTMD FY2024: 1.6%BTMD FY2025: 14.1%CRON FY2019: -163.5%CRON FY2019: 4,549.7%CRON FY2020: -134.6%CRON FY2021: -497.5%CRON FY2022: -154.4%CRON FY2023: -61.5%CRON FY2024: 25.4%CRON FY2025: -4.9%FY19FY20FY21FY22FY23FY24FY25
BTMD 14.1%CRON -4.9%
Revenue growth
BTMD FY2022: +18.3%BTMD FY2023: +12.4%BTMD FY2024: +6.4%BTMD FY2025: -2.5%CRON FY2019: +93.7%CRON FY2020: +112.0%CRON FY2021: +46.5%CRON FY2022: +37.3%CRON FY2023: +10.0%CRON FY2024: +34.5%CRON FY2025: +19.5%FY19FY20FY21FY22FY23FY24FY25
BTMD -2.5%CRON +19.5%
Free cash flow
BTMD FY2021: $32.3MBTMD FY2022: -$9.5MBTMD FY2023: $26.5MBTMD FY2024: $38.8MBTMD FY2025: $30.2MCRON FY2019: -$95.8MCRON FY2019: -$169.9MCRON FY2020: -$176.3MCRON FY2021: -$164.8MCRON FY2022: -$92.4MCRON FY2023: -$45.3MCRON FY2024: $6.4MCRON FY2025: $149KFY19FY20FY21FY22FY23FY24FY25
BTMD $30.2MCRON $149K

Fiscal years as each company reports them; the two may end in different months.

Questions about biote and Cronos

Which is bigger by revenue, biote or Cronos?

Cronos is bigger by revenue: $193.4M in fiscal 2025, against $192.2M for biote in fiscal 2025.

Which keeps more of its revenue as profit, biote or Cronos?

biote had a net margin of 14.1% in fiscal 2025; Cronos had -4.9% in fiscal 2025.

Which grew revenue faster, biote or Cronos?

In their latest fiscal years revenue changed by -2.5% at biote and +19.5% at Cronos.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies